Motor Neuron Disease, Amyotrophic Lateral Sclerosis
13
5
5
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (13)
Functional Outcomes and Control Using Synchron BCI - Australia
Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial
Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neuron Disease.
ALS Research Collaborative
Clinical Characteristics, Natural History, Health Care Measures, and Genetic Screening in Patients With ALS
Non-invasive Spinal, Cortical, and Sensorimotor Biomarkers in Motor Neurone Disease
Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS
NeuroCognitive Communicator: Safety Study
Polysomnographic Titration of Non-invasive Ventilation in Motor Neurone Disease
Telemonitoring in NIV MND (OptNIVent)
Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)
Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis
Music Therapy Protocol to Support Bulbar and Respiratory Functions in ALS